Giuseppe Avvisati from 2016 - present Head of Hematology and Stem Cell Transplant Unit, Campus Bio-Medico University Hospital, Rome; 2008 - present Member of the Scientific Committee of the journal Blood; 2006 - present Council member, Italian Society of Hematology (SIE); 2001 - 2016 Head, Hematology, Transfusion Medicine and Cell Therapy Unit, Campus Bio-Medico University Hospital, Rome; 2003 – 2006 Full Professor of Hematology, Campus Bio-Medico University of Rome (UCBM); 2002 – 2004 Director of the Post-Graduated School in Medical Oncology, UCBM; 2000 – 2003 Associate Professor of Hematology, UCBM; 2000 – 2001 Director of the Post-Graduated School in Internal Medicine, UCBM; 1999 – 2000 Senior researcher, Sapienza University of Rome; 1996 – 2000 Section Editor and Member, Clinical Trial Research Group, Scientific Journal Leukemia; 1993 – 2000 Member, International Myeloma Foundation (IMF); 1986 – 1999 Graduated Technician, Hematology, Sapienza University of Rome; 1990 – 1996 Member Scientific Committee, Scientific Journal Haematologica; 1990 PhD, University of Amsterdam (Holland); 1980 Specialisation diploma in Clinical and Experimental Hematology, Sapienza University of Rome; 1976 Degree in Medicine and Surgery, Sapienza University of Rome.

Prof. Avvisati followed in terms of diagnosis and treatment patients with all malignant tumors, using high specialty diagnostic and therapeutic protocols, also including the transplantation of hematopoietic stem cells. His expertise includes: Acute promyelocytic leukemia, Acute myeloid leukemia, Hodgkin lymphoma, Non Hodgkin lymphoma, Immunoproliferative diseases (multiple myeloma, Waldenstrom macroglobulinemia, cryoglobulinemia, low grade lymphoproliferative disorders), Myelodysplastic syndromes, Idiopathic myelofibrosis, Hemorragic and thrombotic disorders, Chronic myeloproliferative diseases, Poliabortivity due to haematological diseases, Polycythemia vera, Essential thrombocythemia.